These findings suggest that the silencing or mutation of SMAD4 in CCA cells may reduce their immunogenicity and enhance their resistance to immunotherapy by suppressing the endogenous cGAS‐STING1 sensing system. This evidence concerns the gene STING1 and cholangiocarcinoma.